Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4‐Mediated Ferritinophagy Associated with Cisplatin‐Induced Hearing Loss
Advanced Science · 2025
DOI: 10.1002/advs.202408777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Yin Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321 Zhongshan Road, Nan…. Hauptthemen laut MEDLINE: Cisplatin, Hearing Loss, Lignans, Glucosides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Provincial Medical Key Discipline.
Abstract (Originalsprache)
Cisplatin can cause irreversible hearing loss. However, effective approaches to its prevention are not established. In this study, the effect of the traditional Chinese medicine monomer pinoresinol diglucoside (PDG) is evaluated on cisplatin‐induced ototoxicity and its underlying mechanism of action. PDG significantly increases cell viability and inhibits reactive oxygen species production and ferroptosis in cisplatin‐treated House Ear Institute‐Organ of Corti 1 cells and basilar membranes. PDG partially restores hearing loss caused by cisplatin. Transcriptome sequencing identifies Suppressor of Cytokine Signaling 1 (SOCS1), which is significantly elevated in the cisplatin‐only group but significantly reduced after PDG application. SOCS1 is a ferroptosis‐promoting factor, and knocking it down significantly inhibits nuclear receptor coactivator 4 (NCOA4) and inhibits ferritinophagy. Transmission electron microscopy reveals that knocking down SOCS1 reduces the number of autophagic lysosomes induced by cisplatin. Co‐immunoprecipitation is performed to confirm the interaction between SOCS1 and NCOA4. Taken together, these results indicate that PDG inhibits NCOA4‐mediated ferritinophagy by downregulating SOCS1, which reduces cisplatin‐induced ototoxicity. This study provides a new clinical option for the prevention of cisplatin‐induced hearing loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, No. 321 Zhongshan Road, Nanjing, 210008, China.
- Research Institute of Otolaryngology, No. 321 Zhongshan Road, Nanjing, Jiangsu, 210061, China.
- MOE Key Laboratory of Model Animal for Disease Study, Department of Otolaryngology Head and Neck Surgery, Jiangsu Provincial Key Medical Discipline (Laboratory), The Affiliated Drum Tower Hospital of Medical School, Mod…
ORCID-Profile: Xia Gao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Jiangsu Provincial Medical Key Discipline
Zitieren
APA
Chen, Y., Cheng, C., Li, A., Ma, D., Li, S., Wang, H., Gao, S., Liu, D., Song, P., Yu, C., Qian, X., Wan, G., & Gao, X. (2025). Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4‐Mediated Ferritinophagy Associated with Cisplatin‐Induced Hearing Loss. Advanced Science. https://doi.org/10.1002/advs.202408777
Vancouver
Chen Y, Cheng C, Li A, Ma D, Li S, Wang H, et al. Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4‐Mediated Ferritinophagy Associated with Cisplatin‐Induced Hearing Loss. Advanced Science. 2025. doi:10.1002/advs.202408777
BibTeX
@article{Chen2025,
author = {Chen, Yin and Cheng, Cheng and Li, Ao and Ma, Dengbin and Li, Siyu and Wang, Handong and Gao, Song and Liu, Dingding and Song, Panpan and Yu, Chenjie and Qian, Xiaoyun and Wan, Guoqiang and Gao, Xia},
title = {Pinoresinol Diglucoside Attenuates Nuclear Receptor Coactivator 4‐Mediated Ferritinophagy Associated with Cisplatin‐Induced Hearing Loss},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202408777}
}
EUVIMED